High-level viruria as a screening tool for BK virus nephropathy in renal transplant recipients.
10.1016/j.krcp.2016.05.005
- Author:
W James CHON
1
;
Nidhi AGGARWAL
;
Masha KOCHERGINSKY
;
Brenna KANE
;
Jozefa SUTOR
;
Michelle A JOSEPHSON
Author Information
1. Division of Nephrology & Hypertension, University of Arkansas for Medical Sciences, Little Rock, AR, USA. wjameschon@uams.edu
- Publication Type:Original Article
- Keywords:
BK virus;
BK virus nephropathy;
Renal transplant;
Viruria
- MeSH:
Allografts;
Biopsy;
BK Virus*;
Follow-Up Studies;
Humans;
Immunosuppression;
Mass Screening*;
Medical Records;
Retrospective Studies;
Transplant Recipients*;
Viremia
- From:Kidney Research and Clinical Practice
2016;35(3):176-181
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Although early monitoring of BK virus infection in renal transplant patients has led to improved outcomes over the past decade, it remains unclear whether monitoring for viremia is the best screening tool for BK virus nephropathy (BKVN). METHODS: We conducted a retrospective review of the medical records of 368 renal transplant recipients who had a minimum of 18 months of posttransplantation follow-up. The relationship between the presence of BK viruria and a composite end point of BK viremia/BKVN was established, and the predictive value of high-grade BK viruria for development of viremia/BKVN was determined. RESULTS: High grade of BK viruria was present in 110 (30.1%) of the renal transplant recipients. BK viremia/BKVN was present in 64 (17.4%) patients and was 50 times more likely to be present in patients with high-grade BK viruria. The risk of developing BK viremia/BKVN was 3 times higher in high-grade viruria patients, and viruria preceded viremia by nearly 7 weeks. CONCLUSION: The presence of high-grade viruria is an early marker for developing BK viremia/BKVN. Detection of high-grade viruria should prompt early allograft biopsy and/or preemptive reduction in immunosuppression.
